A single arm, open-label multicenter phase II trial of everolimus in patients with relapsed/refractory germ cell cancer (RADIT).
Martin H Fenner
Research Funding - Novartis
Annette Dieing
No relevant relationships to disclose
Karin Oechsle
No relevant relationships to disclose
Marcus Hentrich
No relevant relationships to disclose
Thomas Christoph Gauler
No relevant relationships to disclose
Anja Lorch
No relevant relationships to disclose
Hans-Georg Kopp
No relevant relationships to disclose
Joerg Beyer
No relevant relationships to disclose
Carsten Bokemeyer
No relevant relationships to disclose
Viktor Gruenwald
Honoraria - Novartis
Research Funding - Novartis
Friedemann Honecker
No relevant relationships to disclose